<DOC>
	<DOC>NCT01816152</DOC>
	<brief_summary>Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia</brief_summary>
	<brief_title>Methodology Issues in a Tailored Light Treatment for Persons With Dementia</brief_title>
	<detailed_description>In a within subjects, randomized placebo control study, a tailored light treatment will be used for short-term (4 weeks). Outcome measures include sleep measures (actigraphy), and questionnaires probing behavior and mood in those who have been diagnosed with Alzheimer's disease and related dementia. After a 4-week washout period, a placebo control inactive light will be used for another 4 weeks.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>mild to moderate Alzheimer's disease and related dementia (ADRD) based on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDSADRDA) criteria, Clinical Dementia Rating (CDR) of 1 to 2, MiniMental State Examination (MMSE) between 8 and 24 major organ failure, major illness, history of head injury, hypertension or diabetes, use psychotropic (sleep aid) medicine, obstructing cataracts, macular degeneration, and blindness</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>light treatment</keyword>
	<keyword>circadian rhythms</keyword>
	<keyword>sleep</keyword>
	<keyword>agitation</keyword>
	<keyword>depression</keyword>
</DOC>